Date: 2011-11-21
Type of information: Fundraising
Company: Cytoo (France)
Investors: Sham (France) - Entrepreneurs Fund (EF) (France) - AURIGA Partners (France) - Jacques Lewiner, co-founder and president of the supervisory board at CYTOO.
Amount: €7 million ($10 million)
Funding type: series C financing round
Planned used: CYTOO will use the financing to fully exploit its fast growing business within the global market of cellbased assays and screening, and bring the company up to profitability.
Others: CYTOO has announced the closing of a series C funding round of $ 10M ( €7M). New investors, Sham and Entrepreneurs Fund (EF), led the round. Existing investors AURIGA Partners and Jacques Lewiner, co-founder and president of the supervisory board at CYTOO, also participated.
Leveraging its exclusive technology of adhesive micropatterning, CYTOO’s products and services bring robustness, sensitivity and powerful quantification to cell-based assays, high content analysis and cell screening for the life science research market.
CYTOO holds an exclusive worldwide license from the Institut Curie and the CNRS (The French
national scientific research center) for the adhesive micropattern patent portfolio, as well as license
agreements with Harvard University (USA) and CEA, the largest government-funded technological
research organization in France.
Therapeutic area: Technology - Services
